Transmission of a multidrug-resistant Mycobacterium tuberculosis strain resembling 'strain W' among noninstitutionalized, human immunodeficiency virus-seronegative patients
dc.contributor.author | Van Annelies R. | |
dc.contributor.author | Warren R.M. | |
dc.contributor.author | Beyers N. | |
dc.contributor.author | Gie R.P. | |
dc.contributor.author | Classen C.N. | |
dc.contributor.author | Richardson M. | |
dc.contributor.author | Sampson S.L. | |
dc.contributor.author | Victor T.C. | |
dc.contributor.author | Van Helden P.D. | |
dc.date.accessioned | 2011-05-15T16:03:34Z | |
dc.date.available | 2011-05-15T16:03:34Z | |
dc.date.issued | 1999 | |
dc.description.abstract | Since 1990, several outbreaks of multidrug-resistant tuberculosis (MDR- TB) have been described among institutionalized patients infected with human immunodeficiency virus (HIV). We describe a community MDR-TB outbreak among HIV-seronegative patients in Cape Town, South Africa. Isolates were characterized by restriction fragment length polymorphism (RFLP) analysis and dot-blot hybridization analysis of mutations conferring resistance for isoniazid, rifampin, streptomycin, and ethambutol. All isolates were identical on RFLP analysis. In 2 patients, RFLP analysis showed exogenous reinfection during or after treatment for drug-susceptible TB. Mutation analysis confirmed the genotypic identity of the isolates. The infecting strain was genotypically related to strain W, which is responsible for the majority of MDR-TB outbreaks in New York City. Transmission of MDR-TB is thus not limited to HIV-seropositive patients in an institutional setting but occurs within a community. | |
dc.description.version | Article | |
dc.identifier.citation | Journal of Infectious Diseases | |
dc.identifier.citation | 180 | |
dc.identifier.citation | 5 | |
dc.identifier.issn | 221899 | |
dc.identifier.other | 10.1086/315054 | |
dc.identifier.uri | http://hdl.handle.net/10019.1/12681 | |
dc.subject | ethambutol | |
dc.subject | ethionamide | |
dc.subject | isoniazid | |
dc.subject | rifampicin | |
dc.subject | streptomycin | |
dc.subject | thioacetazone | |
dc.subject | adolescent | |
dc.subject | adult | |
dc.subject | article | |
dc.subject | bacterium isolate | |
dc.subject | child | |
dc.subject | clinical article | |
dc.subject | controlled study | |
dc.subject | disease transmission | |
dc.subject | female | |
dc.subject | gene mutation | |
dc.subject | genotype | |
dc.subject | hospital infection | |
dc.subject | human | |
dc.subject | human immunodeficiency virus infection | |
dc.subject | male | |
dc.subject | multidrug resistance | |
dc.subject | mycobacterium tuberculosis | |
dc.subject | nonhuman | |
dc.subject | nucleotide sequence | |
dc.subject | priority journal | |
dc.subject | South Africa | |
dc.subject | Adolescent | |
dc.subject | Adult | |
dc.subject | Antitubercular Agents | |
dc.subject | Blotting, Southern | |
dc.subject | Child | |
dc.subject | Disease Outbreaks | |
dc.subject | Female | |
dc.subject | HIV Seronegativity | |
dc.subject | Humans | |
dc.subject | Institutionalization | |
dc.subject | Male | |
dc.subject | Microbial Sensitivity Tests | |
dc.subject | Middle Aged | |
dc.subject | Mycobacterium tuberculosis | |
dc.subject | Polymorphism, Restriction Fragment Length | |
dc.subject | South Africa | |
dc.subject | Sputum | |
dc.subject | Tuberculosis, Multidrug-Resistant | |
dc.title | Transmission of a multidrug-resistant Mycobacterium tuberculosis strain resembling 'strain W' among noninstitutionalized, human immunodeficiency virus-seronegative patients | |
dc.type | Article |